CM-Path Discovery workstream held ‘The Liquid Biopsy’ Symposium on March 8th 2018.
Following the day members of CM-Path worked in collaboration with CRUK and PHG Foundation to develop a consensus statement.
The Consensus Statement was written in collaboration with:
The PHG Foundation, part of the University of Cambridge, is a non-profit think tank focused on how emerging health technologies can provide more effective, personalised healthcare for patients and citizens.
The Cancer Research UK Precision Medicine team is pioneering a number of collaborative initiatives which aim to tailor treatment and care to individual patients based on the molecular specific make-up of their disease cancer.